Additional treatment not effective to treat pancreatic cancer
Median overall survival was 11.9 months in patients receiving gemcitabine plus erlotinib.
Hematology/Oncology
Tumor recurrence is common in patients with hepatitis C, hepatocellular carcinoma
Direct-acting antivirals pose challenges in patients with hepatitis C and prior hepatocellular carcinoma
Cancer may complicate HIV management
The rates of many cancers increase in in HIV positive individuals.
Digital mammography plus tomosynthesis linked to increased rate of breast cancer diagnosis
The combination of tomosynthesis and digital mammography screening may benefit women with heterogeneously dense breasts.
Increased use of Gardasil 9 for HPV prevention would reduce cervical cancer rates, healthcare costs
The new vaccine protects against 9 types of HPV and 5 cancer-causing strains.
Women advised to undergo breast cancer risk assessment at 40
50% of women studied met the American Cancer Society requirements for early mammography screening.
ASCO recommendations aim to increase HPV vaccination rates
The American Society of Clinical Oncology has released its recommendations to help improve rates of HPV vaccination worldwide.
Low-dose aspirin regimen may reduce risk of certain cancers
A low-dose aspirin regimen was associated with a 3% lower risk of cancer overall.
Contaminated water and cancer
Contaminated water leads to high rates of birth defects, thyroid cancer, and spontaneous abortions.
How effective is aggressive end-of-life cancer care?
Families of patients who receive aggressive end-of-life medical care do not perceive the care as high-quality.
Next post in Newsline
